Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 750.00
Bid: 750.00
Ask: 762.00
Change: -30.00 (-3.85%)
Spread: 12.00 (1.60%)
Open: 750.00
High: 750.00
Low: 750.00
Prev. Close: 780.00
CHRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Aug 2017 09:21

RNS Number : 8883O
Cohort PLC
24 August 2017
 

24 August 2017

COHORT PLC

Director Shareholdings

Cohort plc (the "Company") hereby notifies the market that on 22 August 2017 Andrew Thomis exercised an approved share option granted under the Cohort plc Company Share Option Plan 2006 on 10 August 2014 over 15,189 ordinary shares of 10 pence each in the Company (Ordinary Shares) with an exercise price of 197.5 pence. Mr Thomis sold 8,000 Ordinary Shares from his nominee account at 375.05 pence to cover the exercise cost. It is the intention Mr Thomis's spouse will be the beneficial owner of these 15,189 Ordinary Shares and that they will be held in her nominee account.

In addition, Mr and Mrs Thomis have each sold 5,334 Ordinary Shares from their respective nominee accounts at 375 pence and ISAs in the names of Mr and Mrs Thomis each subsequently repurchased 5,322 Ordinary Shares each at 375.5 pence per Ordinary Share.

Following these transactions, Mr Thomis's interest and that of his persons closely associated in Ordinary Shares will be 118,686, representing 0.29% of the total issues share capital of the Company.

The Company also notifies the market that on 21 August 2017, Simon Walther exercised an approved share option granted under the Cohort plc Company Share Option Plan 2006 on 10 August 2014 over 15,189 Ordinary Shares with an exercise price of 197.5 pence. Mr Walther sold 8,067 Ordinary Shares at a price of 373 pence to cover the exercise cost. Of the balance of 7,122 Ordinary Shares, Mr and Mrs Walther each transferred 3,561 into their respective nominee accounts.

Following these transactions, Simon Walther's interest and that of his persons closely associated in Ordinary Shares is 107,781, representing 0.26% of the total issued share capital of the Company. 

 

Ends

For further information, please contact:

Cohort plc

 

0118 909 0390

Andrew Thomis, Chief ExecutiveSimon Walther, Finance Director

 

 

 

 

 

Investec Bank plc

 

020 7597 5970

Keith Anderson / Daniel Adams

 

 

 

 

 

MHP Communications Limited

 

020 3128 8100

Reg Hoare / Ollie Hoare

 

 

 

NOTES TO EDITORS

Cohort is the parent company of four innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

MASS is a specialist defence and technology business, focused on electronic warfare, information systems and cyber security.

www.mass.co.uk

 

MCL is an expert in the sourcing, design, integration and support of communications and surveillance technology for the defence and security markets.

www.marlboroughcomms.com

 

SEA is an advanced electronic systems and software house operating in the defence, transport and offshore energy markets.

www.sea.co.uk

 

EID designs and manufactures advanced communications systems for the defence and security markets.

www.eid.pt

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGIGDIIBDBGRS
Date   Source Headline
30th Aug 20232:34 pmRNSDirector/PDMR Shareholding
24th Aug 20233:26 pmRNSBlock listing six monthly return
24th Aug 20232:15 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
23rd Aug 20237:00 amRNSContract Win
11th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20231:39 pmRNSTotal Voting Rights
31st Jul 20237:00 amRNSDirector/PDMR Shareholding
19th Jul 20237:00 amRNSPreliminary Results
3rd Jul 20237:00 amRNSTotal Voting Rights
2nd Jun 20238:02 amRNSTotal Voting Rights
30th May 20238:00 amRNSContract Win
26th May 20239:56 amRNSEBT Purchase of Shares
25th May 20237:00 amRNSFull Year Trading Update
22nd May 20233:15 pmRNSEBT Purchase of Shares
15th May 20233:27 pmRNSEBT Purchase of Shares
10th May 20235:56 pmRNSEBT Purchase of Shares
9th May 202311:41 amRNSHolding(s) in Company
9th May 20239:16 amRNSContract Win
2nd May 20232:47 pmRNSDirector/PDMR Shareholding
2nd May 20232:42 pmRNSEBT Purchase of Shares
2nd May 20232:36 pmRNSTotal Voting Rights
27th Apr 20239:00 amRNSContract Announcement
5th Apr 20237:00 amRNSContract Announcement
3rd Apr 202310:30 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSBlock Listing Six Monthly Return
23rd Mar 20237:00 amRNSMASS contracted to supply EW Operation Support
22nd Mar 20237:00 amRNSChess awarded contract extension
14th Mar 202310:30 amRNSDirector/PDMR Shareholding
1st Mar 202312:38 pmRNSTotal Voting Rights
28th Feb 20237:00 amRNSRecording of Investor Presentation
24th Feb 20231:25 pmRNSBlock listing Interim Review
17th Feb 202310:13 amRNSDirector/PDMR Shareholding
15th Feb 202310:30 amRNSDirector/PDMR Shareholding
1st Feb 20239:42 amRNSTotal Voting Rights
27th Jan 20233:30 pmRNSEBT Purchase of Shares
20th Jan 20237:00 amRNSInvestor Presentation
16th Jan 20237:00 amRNSInterim Report 2022
3rd Jan 20234:00 pmRNSEBT Purchase of Shares
3rd Jan 20233:30 pmRNSTotal Voting Rights
22nd Dec 20225:14 pmRNSEBT Purchase of Shares
14th Dec 20224:51 pmRNSHolding(s) in Company
14th Dec 20227:00 amRNSHalf Year Results
5th Dec 202211:30 amRNSNotice of Results
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:36 pmRNSPrice Monitoring Extension
30th Nov 20223:18 pmRNSTotal Voting Rights
24th Nov 20227:00 amRNSMASS awarded contract extension
31st Oct 20224:50 pmRNSTotal Voting Rights
21st Oct 20224:40 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.